Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Valentina Avvakoumova is active.

Publication


Featured researches published by Valentina Avvakoumova.


Aaps Pharmscitech | 2010

Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 1

Jolyon P. Mitchell; Mark Nagel; Cathy Doyle; Rubina Ali; Valentina Avvakoumova; J. David Christopher; Jorge Quiroz; Helen Strickland; Terrence Tougas; Svetlana Lyapustina

The purpose of this study was to compare relative precision of two different abbreviated impactor measurement (AIM) systems and a traditional multi-stage cascade impactor (CI). The experimental design was chosen to provide separate estimates of variability for each impactor type. Full-resolution CIs are useful for characterizing the aerosol aerodynamic particle size distribution of orally inhaled products during development but are too cumbersome, time-consuming, and resource-intensive for other applications, such as routine quality control (QC). This article presents a proof-of-concept experiment, where two AIM systems configured to provide metrics pertinent to QC (QC-system) and human respiratory tract (HRT-system) were evaluated using a hydrofluoroalkane-albuterol pressurized metered dose inhaler. The Andersen eight-stage CI (ACI) served as the benchmark apparatus. The statistical design allowed estimation of precision with each CI configuration. Apart from one source of systematic error affecting extra-fine particle fraction from the HRT-system, no other bias was detected with either abbreviated system. The observed bias was shown to be caused by particle bounce following the displacement of surfactant by the shear force of the airflow diverging above the collection plate of the second impaction stage. A procedure was subsequently developed that eliminated this source of error, as described in the second article of this series (submitted to AAPS PharmSciTech). Measurements obtained with both abbreviated impactors were very similar in precision to the ACI for all measures of in vitro performance evaluated. Such abbreviated impactors can therefore be substituted for the ACI in certain situations, such as inhaler QC or add-on device testing.


Aaps Pharmscitech | 2010

Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 2—Investigation of Bias in Extra-Fine Mass Fraction with AIM-HRT Impactor

Jolyon P. Mitchell; Mark Nagel; Cathy Doyle; Rubina Ali; Valentina Avvakoumova; J. David Christopher; Jorge Quiroz; Helen Strickland; Terrence Tougas; Svetlana Lyapustina

The purpose of this study was to resolve an anomalously high measure of extra-fine particle fraction (EPF) determined by the abbreviated cascade impactor possibly relevant for human respiratory tract (AIM-HRT) in the experiment described in Part 1 of this two-part series, in which the relative precision of abbreviated impactors was evaluated in comparison with a full resolution Andersen eight-stage cascade impactor (ACI). Evidence that the surface coating used to mitigate particle bounce was laterally displaced by the flow emerging from the jets of the lower stage was apparent upon microscopic examination of the associated collection plate of the AIM-HRT impactor whose cut point size defines EPF. A filter soaked in surfactant was floated on top of this collection plate, and further measurements were made using the same pressurized metered-dose inhaler-based formulation and following the same procedure as in Part 1. Measures of EPF, fine particle, and coarse particle fractions were comparable with those obtained with the ACI, indicating that the cause of the bias had been identified and removed. When working with abbreviated impactors, this precaution is advised whenever there is evidence that surface coating displacement has occurred, a task that can be readily accomplished by microscopic inspection of all collection plates after allowing the impactor to sample ambient air for a few minutes.


Aaps Pharmscitech | 2009

The Abbreviated Impactor Measurement (AIM) Concept: Part II—Influence of Evaporation of a Volatile Component—Evaluation with a “Droplet-Producing” Pressurized Metered Dose Inhaler (pMDI)-Based Formulation Containing Ethanol as Cosolvent

Jolyon P. Mitchell; Mark Nagel; Valentina Avvakoumova; H. MacKay; Rubina Ali

The abbreviated impactor measurement (AIM) concept is a potential solution to the labor-intensive full-resolution cascade impactor (CI) methodology for inhaler aerosol aerodynamic particle size measurement. In this validation study, the effect of increasing the internal dead volume on determined mass fractions relating to aerodynamic particle size was explored with two abbreviated impactors both based on the Andersen nonviable cascade impactor (ACI) operating principle (Copley fast screening Andersen impactor [C-FSA] and Trudell fast screening Andersen impactor [T-FSA]). A pressurized metered dose inhaler-delivered aerosol producing liquid ethanol droplets after propellant evaporation was chosen to characterize these systems. Measures of extrafine, fine, and coarse particle mass fractions from the abbreviated systems were compared with corresponding data obtained by a full-resolution ACI. The use of liquid ethanol-sensitive filter paper provided insight by rendering locations visible where partly evaporated droplets were still present when the “droplet-producing” aerosol was sampled. Extrafine particle fractions based on impactor-sized mass were near equivalent in the range 48.6% to 54%, comparing either abbreviated system with the benchmark ACI-measured data. The fine particle fraction of the impactor-sized mass determined by the T-FSA (94.4 ± 1.7%) was greater than using the C-FSA (90.5 ± 1.4%) and almost identical with the ACI-measured value (95.3 ± 0.4%). The improved agreement between T-FSA and ACI is likely the result of increasing the dead space between the entry to the induction port and the uppermost impaction stage, compared with that for the C-FSA. This dead space is needed to provide comparable conditions for ethanol evaporation in the uppermost parts of these impactors.


Respiratory Care | 2006

The Importance of Nonelectrostatic Materials in Holding Chambers for Delivery of Hydrofluoroalkane Albuterol

Joseph L. Rau; Dominic Coppolo; Mark Nagel; Valentina Avvakoumova; Cathy Doyle; Kimberly Wiersema; Jolyon P. Mitchell


Aaps Pharmscitech | 2009

The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.

Jolyon P. Mitchell; Mark Nagel; Valentina Avvakoumova; H. MacKay; Rubina Ali


Respiratory Care | 2010

A Novel, Versatile Valved Holding Chamber for Delivering Inhaled Medications to Neonates and Small Children: Laboratory Simulation of Delivery Options

Robert M DiBlasi; Dominic Coppolo; Mark Nagel; Cathy Doyle; Valentina Avvakoumova; Rubina Ali; Jolyon P. Mitchell


Archive | 2008

Systems and methods for evaluating medication delivery from valved holding chambers with a facemask using a model face

Myles Limbrick; Robert Morton; Mark Nagel; Jolyon P. Mitchell; Peter Gubbels; Kimberly Wiersema; Cathy Doyle; Valentina Avvakoumova


European Respiratory Journal | 2012

Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique

Jamie Malpass; Mark Nagel; Valentina Avvakoumova; Rubina Ali; Heather Schneider; Jolyon P. Mitchell


European Respiratory Journal | 2014

Inhaled medication delivery to infants via valved holding chamber with facemask: Not all VHCs perform the same

R. Sharpe; Jason Suggett; Mark Nagel; Rubina Ali; Valentina Avvakoumova; Jolyon P. Mitchell


European Respiratory Journal | 2013

Combining inhalation by a breath-actuated nebulizer (BAN) with exhalation with oscillating positive expiratory pressure device (OPEP) offers potential for simultaneous therapy

Jason Suggett; Jolyon P. Mitchell; Valentina Avvakoumova; Rubina Ali; Heather Schneider

Collaboration


Dive into the Valentina Avvakoumova's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph L. Rau

Georgia State University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge